inVentiv Health Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:inVentiv Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013441
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
inVentiv Health Inc (inVentiv) is a Clinical Research Organization (CRO) and Contract Commercial Organization (CCO). The company offers a broad range of clinical development and commercialization services develop and marketing their products and services. Few of its service offerings include Phase I-IIa clinical trials; Phase IIb-III clinical trials; late stage development; bioanalytical services; flexible staffing; consulting, research, sales teams and training; non-personal promotion, public relations, adherence, medical affairs, field medical and nursing teams and management of commercialization. It caters to pharmaceutical, biotechnology, medical device and diagnostics, and healthcare industries. The company operates in North America, South America, Europe, Middle East, Africa, Asia and Australia. inVentiv Health Inc is headquartered in Burlington, Massachusetts, the US.

inVentiv Health Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
inVentiv Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
inVentiv Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
inVentiv Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
inVentiv Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
inVentiv Health Inc, Medical Devices Deals, 2011 to YTD 2017 10
inVentiv Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
inVentiv Health Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
inVentiv Health Acquires Health Division Of Catalina Marketing 12
Venture Financing 13
inVentiv Health Raises USD475 Million in Venture Financing 13
Private Equity 14
Advent International Invests in inVentiv Health 14
Partnerships 16
Pfizer Partners with inVentiv Health 16
Orexo Enters into Commercialization Agreement with inVentiv Health for Zubsolv 17
Proteomics International Enters Into Agreement With inVentiv Health For Biosimilars Development 18
Oncobiologics And inVentiv Health Enter Into Agreement To Develop Biosimilars 19
inVentiv Medical Management Enters Into Agreement With Proventys 20
Merger 21
INC Research and inVentiv Health Merge 21
Palio And Ignite Health Merge To Form Palio+Ignite 23
Acquisition 24
Xerox Acquires inVentiv Patient Access Solutions 24
inVentiv Health Clinical Acquires Stake In Mytrus 25
inVentiv Health Acquires Kazaam Interactive 26
inVentiv Health Acquires Kforce Clinical Research From Kforce For US$50 Million 27
Chandler Chicco Companies Acquires SanCom Creative Communication Solutions, Healthcare Communication Firm 28
Chandler Chicco Companies Acquires Haas & Health Partner, Healthcare Communication Firm 29
inVentiv Health Completes Acquisition Of PharmaNet From JLL Partners 30
inVentiv Health Completes Acquisition Of i3 From Ingenix 32
inVentiv Health Inc – Key Competitors 34
inVentiv Health Inc – Key Employees 35
inVentiv Health Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Joint Venture 39
Recent Developments 40
Strategy And Business Planning 40
Jan 12, 2016: New Clinic in Miami Extends inVentiv Health Phase I Services to the U.S. 40
Corporate Communications 41
May 26, 2016: inVentiv Health Elects David Southwell to Company’s Board of Directors 41
Government and Public Interest 42
Apr 04, 2017: In Mental Health, Payers and Advocacy Groups Agree on Need for More Drug Innovation, but Differ on the Best Roadmap for Clinical Development 42
Other Significant Developments 43
Oct 14, 2016: inVentiv Health Expands Commitment To Elevating Voice Of The Site To Drive Acceleration And Increased Quality Of Trials 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
inVentiv Health Inc, Pharmaceuticals & Healthcare, Key Facts 2
inVentiv Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
inVentiv Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
inVentiv Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
inVentiv Health Inc, Deals By Therapy Area, 2011 to YTD 2017 9
inVentiv Health Inc, Medical Devices Deals, 2011 to YTD 2017 10
inVentiv Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
inVentiv Health Acquires Health Division Of Catalina Marketing 12
inVentiv Health Raises USD475 Million in Venture Financing 13
Advent International Invests in inVentiv Health 14
Pfizer Partners with inVentiv Health 16
Orexo Enters into Commercialization Agreement with inVentiv Health for Zubsolv 17
Proteomics International Enters Into Agreement With inVentiv Health For Biosimilars Development 18
Oncobiologics And inVentiv Health Enter Into Agreement To Develop Biosimilars 19
inVentiv Medical Management Enters Into Agreement With Proventys 20
INC Research and inVentiv Health Merge 21
Palio And Ignite Health Merge To Form Palio+Ignite 23
Xerox Acquires inVentiv Patient Access Solutions 24
inVentiv Health Clinical Acquires Stake In Mytrus 25
inVentiv Health Acquires Kazaam Interactive 26
inVentiv Health Acquires Kforce Clinical Research From Kforce For US$50 Million 27
Chandler Chicco Companies Acquires SanCom Creative Communication Solutions, Healthcare Communication Firm 28
Chandler Chicco Companies Acquires Haas & Health Partner, Healthcare Communication Firm 29
inVentiv Health Completes Acquisition Of PharmaNet From JLL Partners 30
inVentiv Health Completes Acquisition Of i3 From Ingenix 32
inVentiv Health Inc, Key Competitors 34
inVentiv Health Inc, Key Employees 35
inVentiv Health Inc, Other Locations 36
inVentiv Health Inc, Subsidiaries 36
inVentiv Health Inc, Joint Venture 39

★海外企業調査レポート[inVentiv Health Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Savara Inc (SVRA):企業の財務・戦略的SWOT分析
    Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Electricity & Water Authority:企業の戦略的SWOT分析
    Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Imagination Technologies Group plc:企業のM&A・事業提携・投資動向
    Imagination Technologies Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imagination Technologies Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Abu Dhabi Water & Electricity Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Water & Electricity Authority (ADWEA) is a government-owned organization provides utility services. The authority researches and develops methods for the production, distribution and consumption of water and electricity efficiently. Through subsidiaries, ADWEA conducts generation, …
  • Solar Frontier KK:電力:M&Aディール及び事業提携情報
    Summary Solar Frontier KK (Solar Frontier), a subsidiary of Showa Shell Sekiyu K.K. is a renewable energy company that offers solar energy equipment. The company develops and manufacturers copper, indium and selenium thin film photovoltaic modules. It develops power plant projects and manages power …
  • Abdullah Al-Othaim Markets Co.:企業の戦略・SWOT・財務分析
    Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report Summary Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Carnival Corporation & plc:企業の戦略・SWOT・財務分析
    Carnival Corporation & plc - Strategy, SWOT and Corporate Finance Report Summary Carnival Corporation & plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • St. George’s University of London-製薬・医療分野:企業M&A・提携分析
    Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider that offers undergraduate and post graduate courses. The university’s undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthc …
  • Development Center for Biotechnology-製薬・医療分野:企業M&A・提携分析
    Summary Development Center for Biotechnology (DCB) is a non-profit organization that provides support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and devel …
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mediware Information Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mediware Information Systems Inc (Mediware), a subsidiary of TPG Capital is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solution …
  • ADx NeuroSciences NV:企業の製品パイプライン分析2018
    Summary ADx NeuroSciences NV (ADx NeuroSciences) is a medical device company that develops proprietary biomarkers for various neurodegenerative diseases. The company offers biomarkers for Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. It also develops and commercializes analyti …
  • Fate Therapeutics Inc (FATE):企業の財務・戦略的SWOT分析
    Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • LiNiu Technology Group:企業の戦略・SWOT・財務分析
    LiNiu Technology Group - Strategy, SWOT and Corporate Finance Report Summary LiNiu Technology Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Humana Inc (HUM):企業の財務・戦略的SWOT分析
    Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Citibank Berhad:企業の戦略的SWOT分析
    Citibank Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Olam International Ltd:企業のM&A・事業提携・投資動向
    Olam International Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Olam International Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoSta …
  • Rotala Plc:企業の戦略・SWOT・財務情報
    Rotala Plc - Strategy, SWOT and Corporate Finance Report Summary Rotala Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • OBI Pharma Inc (4174):製薬・医療:M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆